Epstein Secrets

EFTA00130083 NMS LI S Toxicology Report Report Issued 08/22/2019 17:09 Phone email: PhD. F-ADFT, DADCC-TC, Laboratory Director To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: CONFIDENTIAL Patient Name FT19-03508 M19-019432

MB-PINACA 0.050 ng/mL MDMB-FUBINACA/ EMB- 0.10 ng/mL 5-fluoro-NA-PIC 0.10 ng/mL FUBINACA 5-fluoro-QU-PINAC 0.10 nglmL MMB-CHMICA 0.10 ng/mL ADAMANTYL-FUBINACA 0.20 ng/mL MMB-CHMINACA 0.20 ng/mL ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL A

19044-2208 Phone: Robert A. PAIddlebem. PhD. F-ABFT, DABCC-TC, Laboratory Director Toxicology Report Report Issued 08722/2019 17:09 To: 10074 New York Office of Chief Medical Examiner of Toxicology 0016 Positive Findings: Patient Name Patient ID Chain Age Not Given Gender Workorder Pago 1 of 2 CONFIDENTIAL FT19

B-PINACA 0.050 ng/mL MDMB-FUBINACA I EMB- 0.10 ng/mL 5-fluoro-NA-PIC 0.10 ng/mL FUBINACA 5-fluoro-QU-PINAC 0.10 ng/mL MMB-CHMICA 0.10 ng/mL ADAMANTYL-FUBINACA 0.20 ng/mL MMB-CHMINACA 0.20 ng/mL ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 rig/mt. MMB-FUBINACA 0.10 ng/mL

il: [email protected] Robert A. MIddleberg, PhD, PABFT, DABCC-TC, Laboratory Director Toxicology Report Report Issued 08/22/2019 17:09 To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name FT19-03508 M19-019432 Patient ID

B-PINACA 0.050 ng/mL MOMS-FUSINACA / EMB- 0.10 ng/mL 5-fluoro-NA-PIC 0.10 nghnL FUBINACA 5-fiuoro-QU-PINAC 0.10 ng/mL MMB-CHMICA 0.10 ng/mL ADAMANTYL-FUBINACA 0.20 ng/mL MMB-CHMINACA 0.20 r.g/mL ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1 0 ng/mL ADMB-FUBICA 1.0 ngIrrL MMB-FUBINACA 0.10 ng/mL

labs.com CONFIDENTIAL t b)(S); (b)(?)(C) jo. F-ABFT, DABCC-TC, Laboratory Director Toxicology Report Report Issued 08/22/201917:09 To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name Patient ID Chain FT19-03508 M19-0

B-PINACA 0.050 ng/mL MDMB-FUBINACA / EMB- 0.10 ng/mL 5-fluoro-NA-PIC 0.10 ng/ml FUBINACA 5-fluoro-OU-PINAC 0.10 ng/ml MMB-CHMICA 0.10 ng/ml ADAMANTYL-FUBINACA 0.20ng/ml MMB-CHMINACA 0.20 ng/mL ADMB-CHMINACA 0.10 ng/ml MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/ml AD

Report Issued 08/22/2019 17:09 NMS Labs 200 Welsh Road, Horsham, PA 19044-2208 PhoneNaas: ( e-mail: DABCC-TC, Laboratory Director To: 10074 New York Office of Chief Medical Examiner Atha. Dopat i mot of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name Patient ID Chain Age Not Given

B-PINACA 0.050 ng/mL MDMB-FUBINACA I EMB- 0.10 ng/mL 5-fluoro-NA-PIC 0.10 ng/mL FUBINACA 5-fluoro-QU-PINAC 0.10 ng/mL MMB-CHMICA 0.10 ng/mL ADAMANTYL-FUBINACA 0.20 ng/mL MMB-CHMINACA 0.20 ng/mL ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL A